NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q1 2023. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $391 | -95.2% | 54 | -95.0% | 0.00% | – |
| Q2 2023 | $8,099 | +419.5% | 1,090 | +384.4% | 0.00% | – |
| Q1 2023 | $1,559 | -75.6% | 225 | -63.8% | 0.00% | – |
| Q4 2022 | $6,394 | +113.1% | 622 | +306.5% | 0.00% | – |
| Q3 2022 | $3,000 | -50.0% | 153 | +34.2% | 0.00% | – |
| Q2 2022 | $6,000 | +50.0% | 114 | +100.0% | 0.00% | – |
| Q1 2022 | $4,000 | -81.0% | 57 | -60.7% | 0.00% | -100.0% |
| Q4 2021 | $21,000 | -40.0% | 145 | -14.2% | 0.00% | 0.0% |
| Q3 2021 | $35,000 | +169.2% | 169 | +168.3% | 0.00% | 0.0% |
| Q2 2021 | $13,000 | +85.7% | 63 | +61.5% | 0.00% | – |
| Q1 2021 | $7,000 | +600.0% | 39 | +680.0% | 0.00% | – |
| Q4 2020 | $1,000 | -96.2% | 5 | -97.9% | 0.00% | -100.0% |
| Q3 2020 | $26,000 | +36.8% | 236 | 0.0% | 0.00% | +100.0% |
| Q2 2020 | $19,000 | +533.3% | 236 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | – | 236 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
| HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
| Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
| Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
| Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
| SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
| Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
| LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
| TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |